@techcrunch.com 15 days ago
Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment
@techcrunch.com 1 year ago
Regard serves as a “medical co-pilot” for busy physicians
@enigmabrains 3 years ago
#JobOpportunity Dr Nikolaos Daskalakis' lab at the Center of Excellence in Depression and Anxiety Disorders @McLeanHospital Harvard Medical School is now seeking to fill a #postdoc position in #MachineLearning of stress and neuropsychiatric disease Info: https://www.nature.com/naturecareers/job/postdoctoral-position-in-machine-learning-of-stress-and-neuropsychiatric-disease-mclean-hospital-727755
@thenextweb.com 6 years ago
How an out-of-body VR experience changed my views on dying
@venturebeat.com 7 years ago
Oncomfort wins award for helping cancer patients manage anxiety through VR
@techcrunch.com 8 years ago
Mental Health Startup Lantern Raises $17 Million Series A Round
@WIRED 8 years ago
A comprehensive analysis of the use of psychedelics for anxiety, PTSD, and addiction shows serious medical potential for the drugs. (via The Daily Beast)